Drugs / Rincell-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07032038 | May 2026 → Nov 2027 expected | auditory neuropathy, presbycusis | Rinri Therapeutics | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rincell-1 | “Rinri Therapeutics is conducting a clinical trial of a new cell therapy called Rincell-1.” NCT07032038 ↗ |
| Modality | Cell therapy | “a new cell therapy called Rincell-1” NCT07032038 ↗ |